Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Generation of two human isogenic iPSC lines from fetal dermal fibroblasts.

Tandon R, Brändl B, Baryshnikova N, Landshammer A, Steenpaß L, Keminer O, Pless O, Müller FJ.

Stem Cell Res. 2018 Dec;33:120-124. doi: 10.1016/j.scr.2018.10.004. Epub 2018 Oct 12.

2.

NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma.

von Boehmer L, Mattle M, Bode P, Landshammer A, Schäfer C, Nuber N, Ritter G, Old L, Moch H, Schäfer N, Jäger E, Knuth A, van den Broek M.

Cancer Immun. 2013 Jul 15;13:12. Print 2013.

3.

A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy.

Gupta A, Nuber N, Esslinger C, Wittenbrink M, Treder M, Landshammer A, Noguchi T, Kelly M, Gnjatic S, Ritter E, von Boehmer L, Nishikawa H, Shiku H, Old L, Ritter G, Knuth A, van den Broek M.

Cancer Immun. 2013;13:3. Epub 2013 Jan 15.

4.

Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation.

Gupta A, Probst HC, Vuong V, Landshammer A, Muth S, Yagita H, Schwendener R, Pruschy M, Knuth A, van den Broek M.

J Immunol. 2012 Jul 15;189(2):558-66. doi: 10.4049/jimmunol.1200563. Epub 2012 Jun 8.

Supplemental Content

Loading ...
Support Center